Expression of E-cadherin, β-catenin and p120ctn in the pulmonary sclerosing hemangioma
- 1 July 2007
- journal article
- research article
- Published by Elsevier in Lung Cancer
- Vol. 57 (1), 54-59
- https://doi.org/10.1016/j.lungcan.2007.02.008
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Abnormal β-Catenin and Reduced Axin Expression Are Associated With Poor Differentiation and Progression in Non–Small Cell Lung CancerAmerican Journal of Clinical Pathology, 2006
- Immunohistochemical and ultrastructural markers suggest different origins for cuboidal and polygonal cells in pulmonary sclerosing hemangiomaHuman Pathology, 2004
- Sixteen Cases of Sclerosing Hemangioma of the Lung Including Unusual PresentationsJournal of Korean Medical Science, 2004
- Pulmonary Sclerosing Hemangioma With Lymph Node MetastasesArchives of Pathology & Laboratory Medicine, 2003
- Pulmonary Sclerosing Hemangioma Consistently Expresses Thyroid Transcription Factor-1 (TTF-1)The American Journal of Surgical Pathology, 2000
- A Clinicopathologic Study of 100 Cases of Pulmonary Sclerosing Hemangioma With Immunohistochemical StudiesThe American Journal of Surgical Pathology, 2000
- Utility of surfactant protein B precursor and thyroid transcription factor 1 in differentiating adenocarcinoma of the lung from malignant mesotheliomaHuman Pathology, 1999
- Sclerosing Lung HemangiomaThe American Journal of Surgical Pathology, 1999
- Sclerosing haemangiomas of the lungHistopathology, 1986
- Sclerosing hemangioma (histiocytoma, xanthoma) of the lungCancer, 1956